{
    "2018-05-08": [
        [
            {
                "time": "2018-01-02",
                "original_text": "FDA Approves JNJ’s Darzalex in Combination with VMP",
                "features": {
                    "keywords": [
                        "FDA",
                        "Approves",
                        "JNJ",
                        "Darzalex",
                        "VMP"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-05",
                "original_text": "Celgene’s Otezla Witnessed Solid Growth in 1Q18",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Otezla",
                        "Growth",
                        "1Q18"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-06",
                "original_text": "Analyzing Merck’s Revenue in 1Q18",
                "features": {
                    "keywords": [
                        "Merck",
                        "Revenue",
                        "1Q18"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-07",
                "original_text": "5 Dividend Aristocrats Where Analysts See Capital Gains",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Aristocrats",
                        "Analysts",
                        "Capital",
                        "Gains"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-08",
                "original_text": "Celgene’s Pomalyst Saw 24% Growth in 1Q18 Compared to 1Q17",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Pomalyst",
                        "Growth",
                        "1Q18",
                        "1Q17"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "A Look at Biogen’s Cash Flows and Price Performance",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Cash",
                        "Flows",
                        "Price",
                        "Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "How Much Upside Do Anaysts Expect for Biogen Stock?",
                "features": {
                    "keywords": [
                        "Upside",
                        "Analysts",
                        "Biogen",
                        "Stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-11",
                "original_text": "How Amgen’s Aranesp, Epogen and Sensipar Did in 1Q18",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Aranesp",
                        "Epogen",
                        "Sensipar",
                        "1Q18"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-12",
                "original_text": "Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",
                "features": {
                    "keywords": [
                        "Benzinga",
                        "Biotech",
                        "Valeant",
                        "Earnings",
                        "Lipocine",
                        "FDA",
                        "Invivo",
                        "CFO",
                        "Departure"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-04-13",
                "original_text": "It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug.",
                "features": {
                    "keywords": [
                        "FDA",
                        "Approvals",
                        "MSON",
                        "Muscling",
                        "RDHL",
                        "Data",
                        "Aug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}